Clinical Trials Browser

OTHER × irinotecan sucrosofate × Endocrine × Clear all

NCT05385861 2025-08-15

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

Phase 1/2 Enrolling by invitation

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT03837977 2024-12-30

NET02

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine